Gene-based medicines, in the form of DNA, RNA, and ribonuclear proteins, promise to help treat many diseases caused by genetic mutations. But one huge challenge of genetic medicine has been figuring out how to deliver these fragile molecules to the right places in the body. Genedit designs polymer nanoparticles of varied size, charge, and composition that can selectively deliver genetic payloads to specific tissues such as in the lungs or the central nervous system.
News & Insights
News
Explore Companies
Nilo Therapeutics
Mapping the brain-body axis to achieve proper immune balance
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
Latus Bio
Finding precisely tuned viral vectors for gene therapy in CNS disorders
Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors